These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25257291)

  • 1. Efficacy and safety of the glycine transporter-1 inhibitor org 25935 for the prevention of relapse in alcohol-dependent patients: a randomized, double-blind, placebo-controlled trial.
    de Bejczy A; Nations KR; Szegedi A; Schoemaker J; Ruwe F; Söderpalm B
    Alcohol Clin Exp Res; 2014 Sep; 38(9):2427-35. PubMed ID: 25257291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the glycine transporter inhibitor Org 25935 as augmentation to cognitive-behavioral therapy for panic disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
    Nations KR; Smits JA; Tolin DF; Rothbaum BO; Hofmann SG; Tart CD; Lee A; Schipper J; Sjogren M; Xue D; Szegedi A; Otto MW
    J Clin Psychiatry; 2012 May; 73(5):647-53. PubMed ID: 22394471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective glycine uptake inhibitor org 25935 as an adjunctive treatment to atypical antipsychotics in predominant persistent negative symptoms of schizophrenia: results from the GIANT trial.
    Schoemaker JH; Jansen WT; Schipper J; Szegedi A
    J Clin Psychopharmacol; 2014 Apr; 34(2):190-8. PubMed ID: 24525661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot double-blind treatment trial of memantine for alcohol dependence.
    Evans SM; Levin FR; Brooks DJ; Garawi F
    Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glycine reuptake inhibitor Org 25935 decreases ethanol intake and preference in male wistar rats.
    Molander A; Lidö HH; Löf E; Ericson M; Söderpalm B
    Alcohol Alcohol; 2007; 42(1):11-8. PubMed ID: 17098748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycine transporter-1 blockade leads to persistently reduced relapse-like alcohol drinking in rats.
    Vengeliene V; Leonardi-Essmann F; Sommer WH; Marston HM; Spanagel R
    Biol Psychiatry; 2010 Oct; 68(8):704-11. PubMed ID: 20655511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of levetiracetam for the prevention of alcohol relapse in recently detoxified alcohol-dependent patients: a randomized trial.
    Richter C; Effenberger S; Bschor T; Bonnet U; Haasen C; Preuss UW; Heinz A; Förg A; Volkmar K; Glauner T; Schaefer M
    J Clin Psychopharmacol; 2012 Aug; 32(4):558-62. PubMed ID: 22722516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence.
    Anton RF; Kranzler H; Breder C; Marcus RN; Carson WH; Han J
    J Clin Psychopharmacol; 2008 Feb; 28(1):5-12. PubMed ID: 18204334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week, randomized, placebo-controlled trial.
    Likhitsathian S; Uttawichai K; Booncharoen H; Wittayanookulluk A; Angkurawaranon C; Srisurapanont M
    Drug Alcohol Depend; 2013 Dec; 133(2):440-6. PubMed ID: 23906999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.
    Johnson BA; Ait-Daoud N; Bowden CL; DiClemente CC; Roache JD; Lawson K; Javors MA; Ma JZ
    Lancet; 2003 May; 361(9370):1677-85. PubMed ID: 12767733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial.
    Guardia J; Caso C; Arias F; Gual A; Sanahuja J; Ramírez M; Mengual I; Gonzalvo B; Segura L; Trujols J; Casas M
    Alcohol Clin Exp Res; 2002 Sep; 26(9):1381-7. PubMed ID: 12351933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate for treating alcohol dependence: a randomized controlled trial.
    Johnson BA; Rosenthal N; Capece JA; Wiegand F; Mao L; Beyers K; McKay A; Ait-Daoud N; Anton RF; Ciraulo DA; Kranzler HR; Mann K; O'Malley SS; Swift RM; ;
    JAMA; 2007 Oct; 298(14):1641-51. PubMed ID: 17925516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial.
    Johnson BA; Ait-Daoud N; Akhtar FZ; Ma JZ
    Arch Gen Psychiatry; 2004 Sep; 61(9):905-12. PubMed ID: 15351769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase 2, placebo-controlled study of the opioid receptor antagonist LY2196044 for the treatment of alcohol dependence.
    Wong CJ; Witcher J; Mallinckrodt C; Dean RA; Anton RF; Chen Y; Fijal BA; Ouyang H; Dharia S; Sundseth SS; Schuh KJ; Kinon BJ
    Alcohol Clin Exp Res; 2014 Feb; 38(2):511-20. PubMed ID: 24010675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amisulpride does not prevent relapse in primary alcohol dependence: results of a pilot randomized, placebo-controlled trial.
    Marra D; Warot D; Berlin I; Hispard E; Notides C; Tilikete S; Payan C; Lépine JP; Dally S; Aubin HJ
    Alcohol Clin Exp Res; 2002 Oct; 26(10):1545-52. PubMed ID: 12394288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial.
    Addolorato G; Leggio L; Ferrulli A; Cardone S; Bedogni G; Caputo F; Gasbarrini G; Landolfi R;
    Alcohol Alcohol; 2011; 46(3):312-7. PubMed ID: 21414953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients.
    Guardia J; Roncero C; Galan J; Gonzalvo B; Burguete T; Casas M
    Addict Behav; 2011 Mar; 36(3):265-9. PubMed ID: 21146937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial.
    Soyka M; Koller G; Schmidt P; Lesch OM; Leweke M; Fehr C; Gann H; Mann KF;
    J Clin Psychopharmacol; 2008 Jun; 28(3):317-24. PubMed ID: 18480689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A double blind placebo controlled randomized clinical trial of the efficacy and safety of pregabalin in induction of remission in patients with alcohol dependence].
    Krupitsky EM; Rybakova KV; Skurat EP; Semenova NV; Neznanov NG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(1):33-43. PubMed ID: 32105267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.